Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. David L. Bartlett

Dr. David L. Bartlett

Chair, Allegheny Health Network Cancer Institute

Dr. David Bartlett is an innovative surgical oncologist who treats patients with peritoneal mesothelioma and other abdominal malignancies at the Allegheny Health Network Cancer Institute in Pittsburgh.

Get in touch
Jump to a Topic:

About David L. Bartlett

  • Peritoneal Mesothelioma icon

    Peritoneal Mesothelioma

  • Top Doctor icon

    Top Doctor

  • Mesothelioma Pioneer icon

    Mesothelioma Pioneer

  • 20+ Years of Experience icon

    20+ Years of Experience

  • Gene Therapy icon

    Gene Therapy

  • Heated Chemotherapy icon

    Hyperthermic Intraperitoneal Chemotherapy

Get to Know Dr. David Bartlett

Surgical oncologist Dr. David Bartlett, a long-time pioneer in advancing the treatment of abdominal malignancies, was named chair of the Allegheny Health Network Cancer Institute in 2020.

Bartlett spent two decades at the nearby University of Pittsburgh Medical Center. He carved out a reputation as a visionary in both research and clinical practice, specializing in treating peritoneal mesothelioma.

Through the years, Bartlett played a leading role in refining the hyperthermic intraperitoneal chemoperfusion (HIPEC) procedure that is used so successfully today for several abdominal cancers. The procedure, combined with cytoreductive surgery, administers chemotherapeutic drugs directly to the peritoneal cavity.

Success with that combination has helped many patients with peritoneal mesothelioma live 10 years or more after being diagnosed, a dramatic improvement from two decades ago.

Bartlett also treats appendiceal, gastric, colon and ovarian cancer and has continued his research work, which includes gene therapy and the use of a laboratory altered version of the smallpox vaccine to fight cancer. Mesothelioma Guide

Get a Free Mesothelioma Guide

Free information, books, wristbands and more for patients and caregivers.

Get Your Free Guide

Specialties of Dr. David Bartlett

  • Peritoneal mesothelioma

  • Hyperthermic intraperitoneal chemoperfusion

  • Ovarian cancer

  • Appendiceal cancer

  • Colon cancer

  • Immunotherapy

  • Cytoreductive surgery

  • Gene therapy

Dr. David Bartlett’s Experience and Medical Education

  • Allegheny Health Network Cancer Institute

  • University of Pittsburgh Medical Center

  • National Cancer Institute

  • MD Anderson Cancer Center (Fellowship)

  • Memorial Sloan Kettering Cancer Center (Fellowship)

  • Perelman School of Medicine, University of Pennsylvania (Residency)

  • University of Texas School of Medicine (MD)

Awards and Other Recognitions

  • Society of Surgical Oncology (President)

  • Lifetime Achievement Award

  • Healthgrades Honor Roll

  • America’s Top Doctors

  • America’s Top Doctors for Cancer

Clinical Trials Under Dr. David Bartlett

  • Phase I clinical trial to determine the safest dosage level when using the combination of celecoxib, interferon alfa and rintatolimod and given with a DC vaccine for peritoneal surface malignancies.

  • Phase I clinical trial to determine safe dosage levels of the drug oxaliplatin when delivered by hepatic perfusion for unresectable colorectal liver disease.

Administrative Role for Dr. David Bartlett

Bartlett intends to continue treating patients and breaking new ground in research, despite an ever-expanding administrative role at the Allegheny Health Network.

As chair of the network’s cancer institute, he will oversee a team of more than 200 physicians, 500 advanced-practice oncology professionals and the network’s oncology clinical trial and laboratory research programs.

Allegheny Health Network is expected to open an $80 million academic center in 2021 that will include a genomics lab and a precision medicine and immunotherapy program.

Bartlett is accustomed to juggling different roles. While at the University of Pittsburgh Medical Center, he served as vice chair for surgical oncology and gastrointestinal surgery services; director of the David C. Koch Regional Perfusion Cancer Therapy Center; and chief of surgery for UPMC Shadyside Hospital.

See More Top Mesothelioma Doctors

Publications of Dr. David Bartlett

  • Kaltenmeier, C., et al. (2019, December 10). Time to Surgery and Colon Cancer Survival in the United States. Annals of Surgery.

  • Kiran, K.K. et al. (2018, May 15). Together We Make a Difference. Gastrointestinal Oncology.

  • Bartlett, D.L. (2008, May). HIPEC: The Complexities of Clinical Trials. Annals of Surgical Oncology.

Disclaimer: Dr. David L. Bartlett has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Allegheny Health Network. (2019, November 7). Internationally Recognized UPMC Cancer Surgeon Joins AHN as Cancer Institute Chair. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified August 2, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now